SEACROSS PHARMACEUTICALS LTD
Get an alert when SEACROSS PHARMACEUTICALS LTD files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£4.6m
+17.6% highest in 6 filed years
Net assets
£2.8m
+30.6% vs 2024
Employees
4
0% vs 2024
Profit before tax
£651k
+135.8% vs 2024
Net assets
6-year trend · vs Health Care median
Accounts
6-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | £7,492,444 | £8,234,694 | +9.9% | |
| Operating profit | — | — | — | — | -£1,568,783 | £475,357 | +130.3% | |
| Profit before tax | — | — | — | — | -£1,819,518 | £650,620 | +135.8% | |
| Net profit | — | — | — | — | -£1,771,238 | £650,620 | +136.7% | |
| Cash | £453,213 | £2,327,962 | £3,123,904 | £3,231,883 | £3,875,846 | £4,558,716 | +17.6% | |
| Total assets less current liabilities | £1,833,416 | £2,574,409 | £3,249,769 | £3,900,104 | £2,128,866 | £2,779,486 | +30.6% | |
| Net assets | — | — | — | — | £2,128,866 | £2,779,486 | +30.6% | |
| Equity | £1,833,416 | £2,574,409 | £3,249,769 | £3,900,104 | £2,128,866 | £2,779,486 | +30.6% | |
| Average employees | 5 | 4 | 4 | 4 | 4 | 4 | 0% | |
| Wages | — | — | — | — | £300,076 | £257,573 | -14.2% | |
| Directors' remuneration | — | — | — | — | £115,872 | £115,872 | 0% | |
| Directors' pension contributions | — | — | — | — | £6,064 | £5,665 | -6.6% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|---|---|---|
| Operating margin | — | — | — | — | -20.9% | 5.8% | |
| Net margin | — | — | — | — | -23.6% | 7.9% | |
| Return on capital employed | — | — | — | — | -73.7% | 17.1% | |
| Gearing (liabilities / total assets) | — | — | — | — | 77.0% | 79.1% | |
| Current ratio | — | — | — | — | 1.11x | 1.14x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Ad Valorem Audit Services Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements are prepared on a going concern basis as the parent company has confirmed its willingness to support the company for at least 12 months from the date of the approval of these financial statements.”
Group structure
- SEACROSS PHARMACEUTICALS LTD · parent
- Seacross Pharmaceuticals (Sichuan) Limited 77.58%
- Seacross Pharma (Europe) Limited 100%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 6 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HE, Ping | Secretary | 2014-11-24 | — | — |
| DING, Yao | Director | 2024-01-01 | Jan 2000 | Chinese |
| DING, Zhao, Dr | Director | 2012-01-01 | Oct 1985 | Chinese |
| HE, Ping | Director | 2015-01-06 | Oct 1972 | Chinese |
Show 6 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ANTHONY, Marc Hourigan | Secretary | 2014-10-30 | 2015-01-20 |
| ATTFIELD, Julian Michael Stuart | Secretary | 2011-05-31 | 2014-10-15 |
| ANDREWS, Douglas Bruce | Director | 2011-05-31 | 2014-10-15 |
| ATTFIELD, Julian Michael Stuart | Director | 2011-05-31 | 2014-10-15 |
| CHANG, Fengkai | Director | 2012-01-01 | 2013-04-26 |
| HOURIGAN, Marc Anthony | Director | 2014-06-04 | 2015-01-06 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Qianyi Huang | Individual | Shares 25–50% (as firm) | 2016-04-06 | Ceased 2022-02-09 |
| Dr Zhao Ding | Individual | Shares 25–50% (as firm) | 2016-04-06 | Active |
Filing timeline
Last 20 of 64 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-10-01 | AA | accounts | Accounts with accounts type full | |
| 2026-06-27 | PSC04 | persons-with-significant-control | Change to a person with significant control | |
| 2026-06-26 | CH01 | officers | Change person director company with change date | |
| 2026-06-26 | CH01 | officers | Change person director company with change date | |
| 2026-06-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-06-17 | PSC04 | persons-with-significant-control | Change to a person with significant control | |
| 2026-05-28 | CH03 | officers | Change person secretary company with change date | |
| 2025-09-09 | AA | accounts | Accounts with accounts type small | |
| 2025-06-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-09-30 | AA | accounts | Accounts with accounts type small | |
| 2024-06-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-02-26 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2024-02-15 | AP01 | officers | Appoint person director company with name date | |
| 2023-09-19 | AA | accounts | Accounts with accounts type small | |
| 2023-06-01 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-05-09 | CH01 | officers | Change person director company with change date | |
| 2023-02-01 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2022-08-22 | AA | accounts | Accounts with accounts type small | |
| 2022-06-01 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-02-09 | PSC07 | persons-with-significant-control | Cessation of a person with significant control |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 7
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.